Zhao Junjun, Yu Menggang, Feng Xi-Ping
Department of General Dentistry, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, 639 Zhi Zao Ju Road, Shanghai, 200011, P.R. China.
Department of Biostatistics & Medical Informatics, University of Wisconsin, K6/446 CSC 600 Highland Ave., Madison, Wisconsin, USA.
BMC Med Res Methodol. 2015 Jun 7;15:48. doi: 10.1186/s12874-015-0039-5.
Simon's two-stage designs are popular choices for conducting phase II clinical trials, especially in the oncology trials to reduce the number of patients placed on ineffective experimental therapies. Recently Koyama and Chen (2008) discussed how to conduct proper inference for such studies because they found that inference procedures used with Simon's designs almost always ignore the actual sampling plan used. In particular, they proposed an inference method for studies when the actual second stage sample sizes differ from planned ones.
We consider an alternative inference method based on likelihood ratio. In particular, we order permissible sample paths under Simon's two-stage designs using their corresponding conditional likelihood. In this way, we can calculate p-values using the common definition: the probability of obtaining a test statistic value at least as extreme as that observed under the null hypothesis.
In addition to providing inference for a couple of scenarios where Koyama and Chen's method can be difficult to apply, the resulting estimate based on our method appears to have certain advantage in terms of inference properties in many numerical simulations. It generally led to smaller biases and narrower confidence intervals while maintaining similar coverages. We also illustrated the two methods in a real data setting.
Inference procedures used with Simon's designs almost always ignore the actual sampling plan. Reported P-values, point estimates and confidence intervals for the response rate are not usually adjusted for the design's adaptiveness. Proper statistical inference procedures should be used.
西蒙两阶段设计是进行II期临床试验的常用选择,尤其在肿瘤学试验中,可减少接受无效实验性疗法的患者数量。最近,小山和陈(2008年)讨论了如何对此类研究进行恰当的推断,因为他们发现,与西蒙设计一起使用的推断程序几乎总是忽略实际使用的抽样计划。特别是,他们针对实际第二阶段样本量与计划样本量不同的研究提出了一种推断方法。
我们考虑基于似然比的另一种推断方法。具体而言,我们使用西蒙两阶段设计下相应的条件似然对允许的样本路径进行排序。通过这种方式,我们可以使用常见定义计算p值:即在原假设下获得至少与观察到的检验统计量值一样极端的值的概率。
除了为小山和陈的方法可能难以应用的几种情况提供推断外,在许多数值模拟中,基于我们方法得到的估计在推断性质方面似乎具有一定优势。它通常会导致更小的偏差和更窄的置信区间,同时保持相似的覆盖率。我们还在实际数据设置中展示了这两种方法。
与西蒙设计一起使用的推断程序几乎总是忽略实际抽样计划。报告的反应率的P值、点估计和置信区间通常未针对设计的适应性进行调整。应使用恰当的统计推断程序。